Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Learn more about your ad choices. Visit megaphone.fm/adchoices
Is the NSW curve bending or flattening?
Why vaccinated people shouldn't have more freedoms (quite yet)
Even with high vaccination, we might need more ...
Moderna is coming! What is it again?
NSW's big (risky?) leap to reopening!
What might the next few weeks look like?
I know the vaccine will protect me, but will it protect others?
Why aren't more Indigenous people vaccinated?
Is it fair to wait to reopen until kids are vaccinated?
Boost me baby! Should we all actually have three doses?
Victoria gives up on donut days forever
From COVID-zero to the ultimate balancing act
Why is the "worst month" for NSW in October?
Didn't Victoria do everything right?
Despite 1000+ cases, a sliver of freedom for NSW
Does Pfizer wear off more quickly?
What are the assumptions in the Doherty Model?
Are kids getting sicker with Delta?
Australia's vaccination rollout goes for gold!
If COVID was a play, what act are we in?
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First from NPR